Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To find patent expiry information for Australia
— Pharmaceutical consulting, Australia
For patent information on specific drug portfolios
— Consultant, USA
To follow up IP status of APIs in the Commonwealth of Independent States
— API wholesaler, UK
For research of expired patents on drugs sold in Brazil
— Business analyst, Brazil
To get information on international drug patents
— Patent agent, USA
Generated: May 23, 2017
What is the patent landscape for Combigan, and when can generic versions of Combigan launch?
Combigan is a drug marketed by Allergan and is included in one NDA. There are eight patents protecting this drug and one Paragraph IV challenge.| Patents: | 8 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: see list | 2 |
| Bulk Api Vendors: see list | 1 |
| Clinical Trials: see list | 13 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | COMBIGAN at DailyMed |
| Drug Class | beta-Adrenergic Blocker alpha-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta-Antagonists Adrenergic alpha-Agonists |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | COMBIGAN | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 021398-001 | Oct 30, 2007 | RX | Yes | Yes | 7,030,149 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Allergan | COMBIGAN | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 021398-001 | Oct 30, 2007 | RX | Yes | Yes | 9,474,751 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Allergan | COMBIGAN | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 021398-001 | Oct 30, 2007 | RX | Yes | Yes | 8,133,890 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Allergan | COMBIGAN | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 021398-001 | Oct 30, 2007 | RX | Yes | Yes | 7,323,463 | ► Subscribe | Y | Y | ► Subscribe | ||||||||||||||||
Allergan | COMBIGAN | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 021398-001 | Oct 30, 2007 | RX | Yes | Yes | 7,320,976 | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Orange Book Patents
Available with subscription
Paragraph IV Activity
Available with subscription
Patent Maintenance
Available with subscription
Non-Orange Book Patents
Available with subscription
International Patents
Available with subscription
Supplementary Protection Certificates
Available with subscription
To identify drugs going off patent in the next five years
— Pharmaceutical product development coordinator, Indonesia
To get the patent status of key drugs
— Marketing manager, Chile
To find all manufacturers of a drug with active DMFs
— CEO, specialty pharmaceutical firm, USA
For patent information on systemic antifungals
— Portfolio specialist, USA
To get information on drug patent expirations for the UK
— Commercial analyst, UK
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
